DERIVATIVES MONOACETICOS tripeptide leucine-FENILALANINAALANINA and alanine-Leucine-Phenylalanine is effective to activate NK cells to identify and destroy DIRECTLY THAT IS INTERFERENCE BY THE IMMUNE CELLS TUMOR ABNORMAL cells metastatic, viruses and cells carrying SYSTEM virus, which results in a "Immunotherapy ACTIVE". The invention also relates to use of said tripeptide monoacetyl for the treatment and prophylaxis of cancer and viral diseases, as well as pharmaceutical compositions containing one or both compounds ABOVE, together with a suitable carrier and, optionally, AFTER SUBSTANCES pharmaceutically active.
展开▼